US Stem Cell Inc (USRM)

[Dragon Lady]

Quote LOL, "Call your broker, It's called 12 month trailing earnings per share. The numbers they have released for the last 10q's/10k dictate the calculation. "

WHAT?? LOL !! Call who ??? They have NO FREAKING "TRAILING EARNINGS" (or current earnings)....NONE...and NEVER HAVE....

CALL ANYONE..Santa Clause...Warren Buffett...the President...Einstein if he were still alive and one will find out.....this company has NEVER, EVER, EVER, EVER, EVER, EVER made even ONE CENT of a "profit" let alone ONE CENT of any "earnings" which come AFTER A PROFIT IS MADE....LOL.....TOTALLY FALSE INFO.....

Some bad auto-bot "scraper" site claiming a "trailing earnings of .18 per share" is just DEAD WRONG FALSE INFO.

FIND ONE SEC FILING for USRM, including the most recent SEC filed 10-Q, period ended Sept 30th, 2017 and they are on-target for one of their largest MONEY LOSSES SINCE GOING PUBLIC, around $4 MILLION in LOSSES...no profits and no "earnings"...its in the freaking statement of operations and also peppered throughout the 10-Q where they discuss their GOING CONCERN and LIQUIDITY PROBLEMS also known as LACK OF CASH and LACK OF ABILITY TO PAY BILLS as they HAVE NO PROFITS....LOL...

https://www.sec.gov/Archives/edgar/data/1388319/000118518517002260/usstemcell10q093017.htm

MOST RECENT "TRAILING" SEC 10-Q:

PAGE 8:

"To date, the Company has not generated significant sales revenues in that they remain less than their total operating expenses, has incurred expenses, and has sustained losses."

PAGE 13:

"NOTE 2 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS

The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying financial statements during nine months ended September 30, 2017, the Company incurred net losses of $3,828,368 and has a working capital deficit (current liabilities in excess of current assets) of $5,304,333. These factors among others may indicate that the Company will be unable to continue as a going concern for a reasonable period of time.

The Company’s primary source of operating funds in 2016 and 2017 has been from revenue generated from sales and cash proceeds from the sale of common stock and the issuance of convertible and other debt. The Company has experienced net losses and negative cash flows from operations since inception, ..."

PAGE 32:

"We are a research and development company and our MyoCell product candidate has not received regulatory approval or generated any material revenues and is not expected generate revenues until the late 2017 or into fiscal 2018, if ever. We have generated substantial net losses and negative cash flow from operations since inception and anticipate incurring significant net losses and negative cash flows from operations for the foreseeable future as we continue clinical trials, undertake new clinical trials, apply for regulatory approvals, make capital expenditures, add information systems and personnel, make payments pursuant to our license agreements upon our achievement of certain milestones, continue development of additional product candidates using our technology, establish sales and marketing capabilities and incur the additional cost of operating as a public company."

WHERE ARE THOSE FANTASY .18 ole supposed... "TRAILING EARNINGS" LOL....WHERE..WHERE...SEC FILING WITH LINK AND PAGE NUMBER PLEASE....cause they DO NOT EXIST and NEVER HAVE EXISTED...

Totally false info being propagated...again...some junk "scraper" site that has it's info wrong does NOT MAKE IT TRUE....SEC EDGAR...thee Federal Govt location for ALL SEC FILINGS for ALL U.S. PUBLIC TRADED COMPANIES...is the ONLY PLACE TO FIND ACCURATE FACTS about a company...and this POS has never, ever, ever, ever, ever HAD ANY "EARNINGS", let alone produced a PROFIT....NEVER.....call a broker...LOL....